KLRC1 and acute lymphoblastic leukemia: These data indicated that the activation induced by the CD19-NKp46-NKCE against BCP-ALL cells can override the inhibitory signal(s) resulting from interaction(s) between iKIR/KIR-L and/or NKG2A/HLA-E.